Astellas Pharma Inc. (4503) : Company Profile and SWOT Analysis

• Publication date: July 2012
• Report size: 45 pages

Synopsis World Market Intelligence's 'Astellas Pharma Inc. (4503) : Company Profile and SWOT Analysis' contains in depth information and data about the company and its operations. The profile contains a company overview, business description, financial ratios, SWOT analysis, competitive benchmarking, key facts, key employees, location and subsidiaries as well as information on products and services. Summary This SWOT an...

Synopsis
World Market Intelligence's 'Astellas Pharma Inc. (4503) : Company Profile and SWOT Analysis' contains in depth information and data about the company and its operations. The profile contains a company overview, business description, financial ratios, SWOT analysis, competitive benchmarking, key facts, key employees, location and subsidiaries as well as information on products and services.

Summary
This SWOT analysis and company profile is a crucial resource for industry executives and anyone looking to gain a better understanding of the company's business.

WMI's 'Astellas Pharma Inc. (4503) : Company Profile and SWOT Analysis' report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format.

WMI strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.

Scope
• Examines and identifies key information and issues about 'Astellas Pharma Inc.' for business intelligence requirements
• Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported
• Provides analysis on financial ratios along with a competitor benchmarking section
• The profile also contains information on business operations, company history, major products and services, key employees

Reasons To Buy
• Quickly enhance your understanding of the company
• Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry
• Recognize potential partnerships and suppliers
• Obtain yearly profitability figures

Key Highlights
Astellas Pharma Inc. (Astellas) is a global pharmaceutical company focused on developing, manufacturing and marketing of pharmaceuticals and related products. The company has research and development capabilities to develop new drugs, manufacturing facilities for the manufacturing of products in a cost effective way and efficient in-house sales force to market those products. The company is active in the field of urology, transplantation and oncology. Key brands marketed by the company include Prograf, Vesicare, Protopic, Harnal and Funguard. Apart from Japan, Astellas supplies its products to global markets, including Ireland, the UK, Netherlands, China, Hong Kong, Thailand, Indonesia, and Philippines, among others. Astellas is headquartered at Chuo-Ku in Tokyo, Japan.

General Medicine And Specialty Medicine Industry in Asia

Table of Contents
1 Business Analysis
1.1 Company Overview
1.2 Business Description
1.3 Major Products and Services
2 Analysis of Key Performance Indicators
2.1 Five Year Snapshot: Overview of Financial and Operational Performance Indicators
2.2 Key Financial Performance Indicators
2.2.1 Revenue and Operating Profit
2.2.2 Asset and Liabilities
2.2.3 Operational Efficiency
2.2.4 Valuation
2.3 Competitive Benchmarking
2.3.1 Market Capitalization
2.3.2 Efficiency
2.3.3 Valuation
2.3.4 Turnover – Inventory and Asset
3 Mergers & Acquisitions and Partnerships
3.1 M&A and Partnerships Strategy
4 SWOT Analysis
4.1 SWOT Analysis - Overview
4.2 Strengths
4.3 Weaknesses
4.4 Opportunities
4.5 Threats
5 History
6 Key Employees
7 Key Employee Biographies
8 Locations and Subsidiaries
8.1 Head Office
8.2 Other Locations and Subsidiaries
9 Appendix
9.1 Methodology
9.2 Ratio Definitions
9.3 Disclaimer

List of Tables
Table 1: Major Products and Services
Table 2: Key Ratios - Annual
Table 3: Key Ratios - Interim
Table 4: Key Capital Market Indicators
Table 5: History
Table 6: Key Employees
Table 7: Key Employee Biographies
Table 8: Subsidiaries
Table 9: Locations

List of Figures
Figure 1: Revenue and Operating Profit
Figure 2: Financial Position
Figure 3: Operational Efficiency
Figure 4: Valuation
Figure 5: Market Capitalization
Figure 6: Efficiency
Figure 7: Valuation
Figure 8: Turnover – Inventory and Asset

Companies mentioned
Astellas Pharma Inc.